Objective:To understand the attitudes and perceptions of traditional Chinese medicine(TCM)practitioners in Beijing TCM hospitals regarding the use of Ephedra sinica Stapf(E.sinica,Ma Huang).Methods:A two-stage cross-s...Objective:To understand the attitudes and perceptions of traditional Chinese medicine(TCM)practitioners in Beijing TCM hospitals regarding the use of Ephedra sinica Stapf(E.sinica,Ma Huang).Methods:A two-stage cross-sectional study was conducted using a questionnaire survey of TCM practi-tioners in Beijing TCM hospitals between April 2023 and March 2024.The questionnaire included de-mographic information,the clinical background of TCM practitioners,and the clinical application of E.sinica.Logistic regression analysis was used to analyze the relevant influencing factors when using E.sinica.Results:Of the 465 questionnaires collected,441 were valid.Among these,84.81%(374/441)reported having used E.sinica in clinical practice at least once.The commonly used doses of E.sinicadexcluding the pediatric departmentdwere 10 g for high doses,6 g for medium,and 3 g for low.The three most frequently used formulas for E.sinica included Maxing Shigan decoction,Mahuang decoction,and Xiao Qing Long decoction.The most common TCM patterns treated with a high dose of E.sinica were wind-cold exterior pattern,wind-cold invading the lung,and wind and water combat with meridians con-gealed by cold.The top three Western medical diagnoses when using E.sinica for treatment were common cold,pneumonia,and upper respiratory tract infections.Nearly half of the respondents reported experiencing adverse reactions from the oral administration of E.sinica,with the most common being palpitations,insomnia,and restlessness.Starting with a low dose and gradually increasing it as appro-priate was identified as an effective approach.Conclusion:This study investigated the attitudes and perceptions of TCM practitioners in Beijing TCM hospitals regarding the doseeefficacyeadverse reaction relationship of E.sinica,providing a reference for the safe and effective clinical use of E.sinica.展开更多
Two polysaccharides (ESP-A1 and ESP-A2) were isolated from the cold water extract of Ephedra sinica Stapf and purified through ethanol precipitation, deproteinization and by ion exchange and gel-filtration chromatogra...Two polysaccharides (ESP-A1 and ESP-A2) were isolated from the cold water extract of Ephedra sinica Stapf and purified through ethanol precipitation, deproteinization and by ion exchange and gel-filtration chromatography. Their molecular weight was determined using high performance size exclusion chromatog-raphy and evaporative light scattering detector (HPSEC-ELSD) and their monosaccharide composition was analyzed by high performance capillary electrophoresis (HPCE) based on pre-column derivatization with 1-phenyl-3-methyl-5-pyrazolone (PMP). It was shown that ESP-A1 consisted of xylose, arabinose, glucose, mannose and galactose and ESP-A2 consisted of xylose, arabinose, rhamnose and galactose, in a molar ratio (%) of 3.2: 61.1: 11.1: 12.9: 11.6 and 20.6: 67.7: 5.0: 6.7, respectively. The molecular weights (Mw) of ESP-A1 and ESP-A2 were 5.83 × 104 Da and more than 200 × 104 Da, respectively. To the best of our knowledge, two neutral polysaccharides are now being reported for the first time in this study.展开更多
基金supported by the Scientific Project of the China Medical Association of Minorities(2023ZY-182-07)and the horizontal project of Beijing University of Chinese Medicine.
文摘Objective:To understand the attitudes and perceptions of traditional Chinese medicine(TCM)practitioners in Beijing TCM hospitals regarding the use of Ephedra sinica Stapf(E.sinica,Ma Huang).Methods:A two-stage cross-sectional study was conducted using a questionnaire survey of TCM practi-tioners in Beijing TCM hospitals between April 2023 and March 2024.The questionnaire included de-mographic information,the clinical background of TCM practitioners,and the clinical application of E.sinica.Logistic regression analysis was used to analyze the relevant influencing factors when using E.sinica.Results:Of the 465 questionnaires collected,441 were valid.Among these,84.81%(374/441)reported having used E.sinica in clinical practice at least once.The commonly used doses of E.sinicadexcluding the pediatric departmentdwere 10 g for high doses,6 g for medium,and 3 g for low.The three most frequently used formulas for E.sinica included Maxing Shigan decoction,Mahuang decoction,and Xiao Qing Long decoction.The most common TCM patterns treated with a high dose of E.sinica were wind-cold exterior pattern,wind-cold invading the lung,and wind and water combat with meridians con-gealed by cold.The top three Western medical diagnoses when using E.sinica for treatment were common cold,pneumonia,and upper respiratory tract infections.Nearly half of the respondents reported experiencing adverse reactions from the oral administration of E.sinica,with the most common being palpitations,insomnia,and restlessness.Starting with a low dose and gradually increasing it as appro-priate was identified as an effective approach.Conclusion:This study investigated the attitudes and perceptions of TCM practitioners in Beijing TCM hospitals regarding the doseeefficacyeadverse reaction relationship of E.sinica,providing a reference for the safe and effective clinical use of E.sinica.
文摘Two polysaccharides (ESP-A1 and ESP-A2) were isolated from the cold water extract of Ephedra sinica Stapf and purified through ethanol precipitation, deproteinization and by ion exchange and gel-filtration chromatography. Their molecular weight was determined using high performance size exclusion chromatog-raphy and evaporative light scattering detector (HPSEC-ELSD) and their monosaccharide composition was analyzed by high performance capillary electrophoresis (HPCE) based on pre-column derivatization with 1-phenyl-3-methyl-5-pyrazolone (PMP). It was shown that ESP-A1 consisted of xylose, arabinose, glucose, mannose and galactose and ESP-A2 consisted of xylose, arabinose, rhamnose and galactose, in a molar ratio (%) of 3.2: 61.1: 11.1: 12.9: 11.6 and 20.6: 67.7: 5.0: 6.7, respectively. The molecular weights (Mw) of ESP-A1 and ESP-A2 were 5.83 × 104 Da and more than 200 × 104 Da, respectively. To the best of our knowledge, two neutral polysaccharides are now being reported for the first time in this study.
